Danaher Completes Acquistion of AB SCIEX and Molecular Devices

Feb 01, 2010

Washington, D.C., February 1, 2010 -- Danaher Corporation (NYSE: DHR) announced today that it has completed the previously announced acquisition of AB SCIEX and Molecular Devices. AB SCIEX is a leading designer and manufacturer of mass spectrometers, highly sensitive and sophisticated instruments used by researchers and clinicians to identify and quantify specific molecules in complex samples. Molecular Devices supplies high-performance bio-analytical instrumentation systems and consumables that accelerate and improve research productivity and effectiveness in life science research and drug discovery.